Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleksandr N Kryvenko

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
International Journal of Surgical Pathology|March 17, 2021
Small Cell-like Change in Central Zone Histology-A New Observation Mimicking Cribriform Intraductal Prostatic AdenocarcinomaOleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Characteristics of the peritumoral pseudocapsule vary predictably with histologic subtype of T1 renal neoplasms. Jacob JM, Williamson SR, Gondim DD, Leese JA, Terry C, Grignon DJ, Boris RS.Urology. November 2015;86(5):956-961Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C, Przybycin CG.Am J Surg Pathol. September 2016;40(9):1224-1231Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34Oleksandr N Kryvenko
Urology|January 29, 2016
Reply by the AuthorsOleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Multilocular cystic renal cell carcinoma: pathological t staging makes no difference to favorable outcomes and should be reclassified. Bhatt JR, Jewett MA, Richard PO, Kawaguchi S, Timilshina N, Evans A, Alibhai S, Finelli A.J Urol. November 2016;196(5):1350-1355Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Do clear cell papillary renal cell carcinomas have malignant potential? Diolombi ML, Cheng L, Argani P, Epstein JI.Am J Surg Pathol. December 2015;39(12):1621-1634Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA, Daignault S, Wolf JS Jr, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Hum Pathol.September 2016;55:1-10Oleksandr N Kryvenko
The Journal of Urology|February 13, 2017
Editorial CommentOleksandr N Kryvenko
The American Journal of Surgical Pathology|March 8, 2022
Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade CarcinomaOleksandr N Kryvenko
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
International Journal of Surgical Pathology|March 17, 2021
Small Cell-like Change in Central Zone Histology-A New Observation Mimicking Cribriform Intraductal Prostatic AdenocarcinomaOleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Characteristics of the peritumoral pseudocapsule vary predictably with histologic subtype of T1 renal neoplasms. Jacob JM, Williamson SR, Gondim DD, Leese JA, Terry C, Grignon DJ, Boris RS.Urology. November 2015;86(5):956-961Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C, Przybycin CG.Am J Surg Pathol. September 2016;40(9):1224-1231Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34Oleksandr N Kryvenko
Urology|January 29, 2016
Reply by the AuthorsOleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Multilocular cystic renal cell carcinoma: pathological t staging makes no difference to favorable outcomes and should be reclassified. Bhatt JR, Jewett MA, Richard PO, Kawaguchi S, Timilshina N, Evans A, Alibhai S, Finelli A.J Urol. November 2016;196(5):1350-1355Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Do clear cell papillary renal cell carcinomas have malignant potential? Diolombi ML, Cheng L, Argani P, Epstein JI.Am J Surg Pathol. December 2015;39(12):1621-1634Oleksandr N Kryvenko
Urologic Oncology|April 19, 2017
Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA, Daignault S, Wolf JS Jr, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Hum Pathol.September 2016;55:1-10Oleksandr N Kryvenko
The Journal of Urology|February 13, 2017
Editorial CommentOleksandr N Kryvenko
The American Journal of Surgical Pathology|March 8, 2022
Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade CarcinomaOleksandr N Kryvenko
Pageof 16